featuring a structure-guided design approach.
human papillomavirus (HPV) vaccines
and many other innovative vaccines
Health Guard ranked among TOP 10 on the list of "2022 Future Healthcare VB100 - Top 100 Innovative Biomedicine Companies"
Beijing Health Guard Approved by NMPA to Commence Clinical Trials of the Recombinant 15-Valent HPV Vaccine
Beijing Health Guard Announces IND Application for the Recombinant 15-valent HPV Vaccine Accepted for Review by NMPA